TORVANTA
Other · S&P 500 · data as of 2026-10-05

RCUS stock analysis: RCUS

RCUS (RCUS) is an S&P 500 company in Other. It grades weakest on profitability.

The model's view of RCUS · subscribers

Where RCUS ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with RCUS · updated 2026-10-05 · from prices and SEC filings

RCUS price performance

RCUS against the S&P 500, one year
+0%+50%+100%RCUS +86%S&P 500 +18%2025-09-292026-10-05
Year to date+3.8%S&P 500 +14.5% · behind by 10.7 pts
1 year+85.3%S&P 500 +17.0% · ahead by 68.3 pts
3 years+51.0%S&P 500 +89.3% · behind by 38.2 pts
5 years-26.4%S&P 500 +91.3% · behind by 117.7 pts

Total returns with dividends reinvested.

RCUS factor grades

Each grade compares RCUS with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

–ValueFCF yield -15.1% (industry 6.0%)
–GrowthRevenue growth -55% (industry +8%)
FProfitabilityROIC -92.5% (industry 10.1%)
C+Momentum12-month change +85%From 52-wk high -22%

RCUS in plain numbers

RCUS key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$3.2B
Revenue growth (y/y)-55%
Free-cash-flow yield-15.1%
Dividend yieldn/a
Next earnings (expected)2026-10-27
Valuation measures
Market value$3.2B
Enterprise value$3.1B
Price / sales26.9x
Price / book6.8x
EV / revenue26.5x
Financial highlights
Revenue, last 12 months$117.0M
Net income, last 12 months-$460.0M
EPS, last 12 months (GAAP)$-3.91
Operating margin-415.4%
Net margin-393.2%
Return on equity-90.8%
Return on invested capital-92.5%
Cash$150.0M
Total debt$101.0M
Debt / equity0.22x
Free cash flow, last 12 months-$475.0M
Current ratio3.82x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

RCUS earnings trends

Revenue vs earnings
-$135.0M-$61.2M$12.5M$86.2M$160.0MSep 2024 Revenue: $48.0MDec 2024 Revenue: $26.0MMar 2025 Revenue: $28.0MJun 2025 Revenue: $160.0MSep 2025 Revenue: $26.0MDec 2025 Revenue: $33.0MMar 2026 Revenue: $17.0MJun 2026 Revenue: $41.0MSep 2024 Net income: -$92.0MDec 2024 Net income: -$94.0MMar 2025 Net income: -$112.0MJun 2025 Net income: $0Sep 2025 Net income: -$135.0MDec 2025 Net income: -$106.0MMar 2026 Net income: -$128.0MJun 2026 Net income: -$91.0MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: -191.7%Net margin: -361.5%Net margin: -400.0%Net margin: 0.0%Net margin: -519.2%Net margin: -321.2%Net margin: -752.9%Net margin: -222.0%-753%-376%0%■ Revenue ■ Net income ━ Net margin
Earnings per share$-1.3$-1.0$-0.6$-0.3$0.0Sep 2024 EPS (GAAP, diluted): $-1.0Dec 2024 EPS (GAAP, diluted): $-1.0Mar 2025 EPS (GAAP, diluted): $-1.1Jun 2025 EPS (GAAP, diluted): $0.0Sep 2025 EPS (GAAP, diluted): $-1.3Dec 2025 EPS (GAAP, diluted): $-0.9Mar 2026 EPS (GAAP, diluted): $-1.0Jun 2026 EPS (GAAP, diluted): $-0.7Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted)

From the company's 10-Q and 10-K filings with the SEC.

RCUS financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$382.9M$112.0M$117.0M$258.0M$247.0M
Net income$52.8M-$267.0M-$307.0M-$283.0M-$353.0M
EPS (GAAP)$0.71$-3.72$-4.15$-3.10$-3.31
Free cash flow-$282.2M$432.0M-$330.0M-$176.0M-$484.0M

RCUS earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-05$-0.72n/a-74%-1.3%
2026-05-05$-1.02n/a-39%-2.4%
2026-02-25$-0.90n/a+27%-3.5%
2025-10-28$-1.27n/a-46%+8.8%
2025-08-06$0.00n/a+310%-3.5%
2025-05-06$-1.14n/a-81%-10.0%

About RCUS

HeadquartersHayward, CA
Industry (SEC code)Pharmaceutical Preparations
Fiscal year endsDecember 31
Incorporated inDE
Listed onNYSE

From the company's SEC registration record.

Companies similar to RCUS

CompanyMarket valueP/ERevenue growthOperating margin12-month change
RCUS RCUS$3.2Bn/a-55%n/a+85%
ASH ASH$3.1B65.5x-1%7.4%+45%compare
KAI KAI$3.2B28.7x+13%15.0%-12%compare
SBCF SBCF$3.1B21.0xn/an/a+8%compare
FA FA$3.2B131.2x+33%10.7%+17%
CBU CBU$3.2B14.0x+10%n/a+6%
PPLI PPLI$3.2B9.3x-32%-9.0%+21%

All Other stock ratings

Frequently asked questions

Is RCUS stock a buy?

Torvanta does not tell individuals what to buy. Its grades for RCUS are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

When does RCUS report earnings next?

Based on its filing history, Torvanta expects RCUS to report around 2026-10-27.

How has RCUS performed against the S&P 500?

Over the past year RCUS returned +85.3%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer